Expanding access to naloxone
This consultation collected views on expanding the use of naloxone. It ran for 8 weeks and was open to all interested individuals and organisations.
Opened
3 Aug 2021
Closed
28 Sep 2021
↓
Linked documents
- Open Consultation Expanding access to naloxone
- Consultation Outcome Expanding access to naloxone: summary of feedback
▤ Verbatim text from source document
Naloxone is a drug that reverses the effects of an opioid overdose and can help to prevent overdose deaths. We are seeking responses to this consultation to assess the viability of proposals to widen access to naloxone by expanding the list of services and individuals that can give it out without a prescription or other written instruction.
The easiest way to participate is by completing the public survey.
The consultation document provides further guidance. We welcome responses from individuals or organisations who have experience or expertise in substance use disorders.